News
7d
News-Medical.Net on MSNShingles and RSV vaccines with AS01 adjuvant reduce dementia riskResearchers found that older adults who received AS01-adjuvanted shingles or RSV vaccines had a significantly lower risk of ...
Individuals who received either the AS01 shingles or RSV vaccine had a significantly lower risk of developing dementia.
New data hint at a role for the AS01 adjuvant in vaccines for herpes zoster and respiratory syncytial virus in protecting ...
11d
MedPage Today on MSNRSV Vaccine Tied to Lower Dementia RiskTwo AS01-adjuvanted vaccines for different pathogens -- the respiratory syncytial virus (RSV) vaccine (Arexvy) and the ...
Compared with flu vaccine recipients, those given the RSV or shingles vaccine had 18% to 37% lower odds of receiving a ...
An ongoing phase 3 study of the efficacy, safety, and immunogenicity of candidate malaria vaccine RTS,S/AS01 is being conducted in seven African countries.From March 2009 through January 2011, we e ...
The most advanced of the current candidates against P. falciparum is RTS,S/AS01, a recombinant vaccine against the pre-erythrocytic stage of the parasite in which regions of P. falciparum ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results